Ticker: FTII

FutureTech II Acquisition Corp. (NASDAQ: FTII) What's happening inside: FTII is a blank‑check (SPAC) vehicle that has not generated operating revenue and is pursuing a proposed business combination with Longevity Biomedical. The company was suspended from Nasdaq trading on February 26, 2025 for f...

FutureTech II Acquisition Corp. (NASDAQ: FTII) has recently released its financial results for the first quarter ended March 31, 2025. The company is focused on achieving a business combination but is facing significant challenges in this regard. Income Statement Highlights: Net Loss: $289,673 f...